JPS61200923A - 抗アレルギ−作用を有する物質とその製造方法 - Google Patents
抗アレルギ−作用を有する物質とその製造方法Info
- Publication number
- JPS61200923A JPS61200923A JP60043188A JP4318885A JPS61200923A JP S61200923 A JPS61200923 A JP S61200923A JP 60043188 A JP60043188 A JP 60043188A JP 4318885 A JP4318885 A JP 4318885A JP S61200923 A JPS61200923 A JP S61200923A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- lower alcohol
- substance
- antiallergic
- residue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000126 substance Substances 0.000 title claims abstract description 13
- 230000003266 anti-allergic effect Effects 0.000 title claims abstract description 9
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims abstract description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 239000000284 extract Substances 0.000 claims abstract description 13
- 239000002244 precipitate Substances 0.000 claims abstract description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 9
- 238000000502 dialysis Methods 0.000 claims abstract description 9
- 238000002523 gelfiltration Methods 0.000 claims abstract description 7
- 239000007864 aqueous solution Substances 0.000 claims abstract description 5
- 238000005342 ion exchange Methods 0.000 claims abstract description 4
- 235000001674 Agaricus brunnescens Nutrition 0.000 claims description 9
- 238000000746 purification Methods 0.000 claims description 5
- 238000007796 conventional method Methods 0.000 claims description 3
- 230000000704 physical effect Effects 0.000 claims description 2
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 12
- 238000000034 method Methods 0.000 abstract description 7
- 230000000694 effects Effects 0.000 abstract description 5
- 239000012528 membrane Substances 0.000 abstract description 5
- 150000001875 compounds Chemical class 0.000 abstract description 4
- 241000001493 Sarcodon aspratus Species 0.000 abstract description 3
- 239000002994 raw material Substances 0.000 abstract description 3
- 229920002678 cellulose Polymers 0.000 abstract description 2
- 239000001913 cellulose Substances 0.000 abstract description 2
- 150000002772 monosaccharides Chemical class 0.000 abstract description 2
- 238000001556 precipitation Methods 0.000 abstract description 2
- 235000013399 edible fruits Nutrition 0.000 abstract 2
- 239000000043 antiallergic agent Substances 0.000 abstract 1
- 239000000047 product Substances 0.000 abstract 1
- 239000000706 filtrate Substances 0.000 description 12
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000011347 resin Substances 0.000 description 6
- 229920005989 resin Polymers 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 239000000427 antigen Substances 0.000 description 5
- 102000036639 antigens Human genes 0.000 description 5
- 108091007433 antigens Proteins 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 4
- 239000003957 anion exchange resin Substances 0.000 description 4
- 239000003729 cation exchange resin Substances 0.000 description 4
- 241000700199 Cavia porcellus Species 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 229940092253 ovalbumin Drugs 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- SPCKHVPPRJWQRZ-UHFFFAOYSA-N 2-benzhydryloxy-n,n-dimethylethanamine;2-hydroxypropane-1,2,3-tricarboxylic acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O.C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 SPCKHVPPRJWQRZ-UHFFFAOYSA-N 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 108010058846 Ovalbumin Proteins 0.000 description 2
- 206010040914 Skin reaction Diseases 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- 239000003463 adsorbent Substances 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 229960000520 diphenhydramine Drugs 0.000 description 2
- 238000001914 filtration Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 239000003456 ion exchange resin Substances 0.000 description 2
- 229920003303 ion-exchange polymer Polymers 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 238000010992 reflux Methods 0.000 description 2
- 230000035483 skin reaction Effects 0.000 description 2
- 231100000430 skin reaction Toxicity 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 206010011655 Cushingoid Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 239000012506 Sephacryl® Substances 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001919 adrenal effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 235000012745 brilliant blue FCF Nutrition 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000000385 dialysis solution Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 238000011597 hartley guinea pig Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- OQUKIQWCVTZJAF-UHFFFAOYSA-N phenol;sulfuric acid Chemical compound OS(O)(=O)=O.OC1=CC=CC=C1 OQUKIQWCVTZJAF-UHFFFAOYSA-N 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 230000002747 voluntary effect Effects 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60043188A JPS61200923A (ja) | 1985-03-04 | 1985-03-04 | 抗アレルギ−作用を有する物質とその製造方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60043188A JPS61200923A (ja) | 1985-03-04 | 1985-03-04 | 抗アレルギ−作用を有する物質とその製造方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS61200923A true JPS61200923A (ja) | 1986-09-05 |
| JPH0541608B2 JPH0541608B2 (da) | 1993-06-24 |
Family
ID=12656941
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP60043188A Granted JPS61200923A (ja) | 1985-03-04 | 1985-03-04 | 抗アレルギ−作用を有する物質とその製造方法 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS61200923A (da) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63297400A (ja) * | 1987-05-29 | 1988-12-05 | Fujimoto Seiyaku Kk | 抗アレルギ−作用を有する物質とその製造方法 |
| JPH0554665U (ja) * | 1991-03-01 | 1993-07-23 | テムコ株式会社 | 自己制御水道凍結防止器 |
| JP2005075740A (ja) * | 2003-08-28 | 2005-03-24 | Hajime Otani | 免疫賦活化組成物、並びにそれが含まれた医薬品、動物薬、食品、飼料及び化粧品 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2001151689A (ja) * | 1999-11-29 | 2001-06-05 | Naris Cosmetics Co Ltd | 皮膚外用剤 |
-
1985
- 1985-03-04 JP JP60043188A patent/JPS61200923A/ja active Granted
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS63297400A (ja) * | 1987-05-29 | 1988-12-05 | Fujimoto Seiyaku Kk | 抗アレルギ−作用を有する物質とその製造方法 |
| JPH0554665U (ja) * | 1991-03-01 | 1993-07-23 | テムコ株式会社 | 自己制御水道凍結防止器 |
| JP2005075740A (ja) * | 2003-08-28 | 2005-03-24 | Hajime Otani | 免疫賦活化組成物、並びにそれが含まれた医薬品、動物薬、食品、飼料及び化粧品 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0541608B2 (da) | 1993-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4409144A (en) | Xeronine, a new alkaloid, useful in medical, food and industrial fields | |
| EP0030444B1 (en) | A process for preparing substances having interferon inducing activity | |
| DE69431024T2 (de) | Neues physiologisch aktives Mittel | |
| US5057324A (en) | Kallikrein inhibitor substance, a process for preparation and pharmaceutical compositions thereof | |
| CN106265754A (zh) | 一种从美洲大蠊中连环提取得到两种有效成分的方法 | |
| JPS6312846B2 (da) | ||
| CA1083137A (en) | Isolation of physiologically active substances | |
| JPS61200923A (ja) | 抗アレルギ−作用を有する物質とその製造方法 | |
| CA2430113A1 (en) | Process for preparing aqueous extracts of plants and extracts so obtained | |
| HU203043B (en) | Process for producing pharmaceutical compositions against tumour and ulcer containing euphorbia hirta l. it's parts or extract | |
| KR0168485B1 (ko) | 산성다당체를 다량 함유하는 홍삼엑기스 제조방법 | |
| CN119264286A (zh) | 一种石斛多糖及其制备方法和应用 | |
| CN108997509B (zh) | 一种分心木多糖、分心木多糖的制备方法及用途 | |
| DE19600301C2 (de) | Durch Cyclooligomerisierung des einfachen Kohlensuboxids C¶3¶O¶2¶ aufgebaute makrocyclische Verbindungen, Verfahren zu deren Herstellung und Gewinnung sowie deren Verwendung | |
| CH634854A5 (de) | Verfahren zur herstellung organopeptidhaltiger substanzen mit insulinaehnlicher wirksamkeit aus blut oder blutbestandteilen. | |
| GB2101888A (en) | Vegetable/animal extracts | |
| JP4480204B2 (ja) | カワリハラタケの抗腫瘍性画分 | |
| KR0124969B1 (ko) | 백삼박으로부터 산성 다당체의 제조방법 | |
| DE1293705B (de) | Verfahren zur Gewinnung eines elastolytisch wirksamen Bauchspeicheldruesen-Praeparates | |
| US3172813A (en) | Process for preparation of kidney extracts | |
| AU2021100051A4 (en) | Antitumor formula and extraction method thereof | |
| US3919186A (en) | Method of recovering cytobiotic globulin from skin tissue | |
| JPS6372629A (ja) | 霊芝から生理活性エキスを製造する方法 | |
| JPS6338325B2 (da) | ||
| JPS56102787A (en) | Preparation of human placenta superoxide dismutase |